Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy
T Sauerer, GF Velázquez, C Schmid - Molecular Cancer, 2023 - Springer
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by the expansion
of immature myeloid cells in the bone marrow (BM) and peripheral blood (PB) resulting in …
of immature myeloid cells in the bone marrow (BM) and peripheral blood (PB) resulting in …
Understanding and harnessing the graft‐versus‐leukaemia effect
AJ Barrett - British journal of haematology, 2008 - Wiley Online Library
The graft‐versus‐leukaemia (GVL) effect is a central component of the stem cell allograft's
ability to cure haematological malignancies. The GVL effect is mediated by donor‐derived …
ability to cure haematological malignancies. The GVL effect is mediated by donor‐derived …
Phenotypic complexity of the human regulatory T cell compartment revealed by mass cytometry
Regulatory T cells (Tregs) are an essential component of the cellular immune response,
occupying a key role in maintaining immunological tolerance and present an attractive …
occupying a key role in maintaining immunological tolerance and present an attractive …
[HTML][HTML] Blocking migration of regulatory T cells to leukemic hematopoietic microenvironment delays disease progression in mouse leukemia model
R Wang, W Feng, H Wang, L Wang, X Yang, F Yang… - Cancer Letters, 2020 - Elsevier
Blocking the migration of regulatory T cells (Tregs) to the tumor microenvironment is a
promising strategy for tumor immunotherapy. Treg accumulation in the leukemic …
promising strategy for tumor immunotherapy. Treg accumulation in the leukemic …
Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma
S Mittal, NA Marshall, L Duncan… - Blood, The Journal …, 2008 - ashpublications.org
Regulatory T (Treg) cells contribute to immune evasion by malignancies. To investigate their
importance in non-Hodgkin lymphoma (NHL), we enumerated Treg cells in peripheral blood …
importance in non-Hodgkin lymphoma (NHL), we enumerated Treg cells in peripheral blood …
Regulation of hematopoietic and leukemia stem cells by regulatory T cells
C Riether - Frontiers in immunology, 2022 - frontiersin.org
Adult bone marrow (BM) hematopoietic stem cells (HSCs) are maintained in a quiescent
state and sustain the continuous production of all types of blood cells. HSCs reside in a …
state and sustain the continuous production of all types of blood cells. HSCs reside in a …
Epigenetics, autoimmunity and hematologic malignancies: a comprehensive review
O Ngalamika, Y Zhang, H Yin, M Zhao… - Journal of …, 2012 - Elsevier
The relationships between immunological dysfunction, loss of tolerance and hematologic
malignancies have been a focus of attention in attempts to understand the appearance of a …
malignancies have been a focus of attention in attempts to understand the appearance of a …
Increased CD200 expression in acute myeloid leukemia is linked with an increased frequency of FoxP3+ regulatory T cells
3 Gaikwad A, Rye CL, Devidas M, Heerema NA, Carroll AJ, Izraeli S et al. Prevalence and
clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia. Br J …
clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia. Br J …
Regulatory T cells and their prognostic relevance in hematologic malignancies
G D'Arena, C Vitale, M Coscia, A Festa… - Journal of …, 2017 - Wiley Online Library
Regulatory T cells (Tregs) have a fundamental function in monitoring the immune
homeostasis in healthy individuals. In cancer and, in particular, in hematological …
homeostasis in healthy individuals. In cancer and, in particular, in hematological …
CC chemokine receptor 8 potentiates donor Treg survival and is critical for the prevention of murine graft-versus-host disease
JM Coghill, KA Fowler, ML West… - Blood, The Journal …, 2013 - ashpublications.org
The infusion of donor regulatory T cells (Tregs) has been used to prevent acute graft-versus-
host disease (GVHD) in mice and has shown promise in phase 1 clinical trials. Previous …
host disease (GVHD) in mice and has shown promise in phase 1 clinical trials. Previous …